Skip to main content
Peter Shields, MD, Oncology, Columbus, OH, The OSUCCC - James

PeterGaryShieldsMD

Oncology Columbus, OH

Hematologic Oncology, Thoracic Cancer

Deputy Director, The Ohio State University Comprehensive Cancer Center & Professor of Medicine, The Ohio State University

Dr. Shields is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shields' full profile

Already have an account?

Summary

  • Dr. Peter Shields is an oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 34 years. He specializes in hematologic oncology and thoracic cancer and is experienced in hematologic oncology, public health, epidemiology, thoracic oncology, and cancer prevention.

Education & Training

  • NIH Clinical Center
    NIH Clinical CenterPost-Doctoral Fellowship, National Cancer Institute, 1987 - 1990
  • George Washington University
    George Washington UniversityFellowship, Hematology and Medical Oncology, 1987 - 1988
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 1983 - 1986
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1983
  • University of Pennsylvania
    University of PennsylvaniaBA, Biochemistry and American Civilization, Magna Cum Laude, 1979

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2012 - 2026
  • VA State Medical License
    VA State Medical License 1985 - 2016
  • DC State Medical License
    DC State Medical License 1985 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2017
  • America's Top Doctors for Cancer Castle Connolly, 2005-2015
  • Joseph Cullen Award American Society of Preventive Oncology, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database  
    Kai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central
  • Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses  
    Haraldsdottir S, Hampel H, Wu C, Weng DY, Shields PG, Frankel WL, Pan X, de la Chapelle A, Goldberg RM, Bekaii-Saab T, Genet Med, 1/11/2016
  • Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from healthy women  
    Song MA, Brasky TM, Marian C, Weng DY, Taslim C, Llanos AA, Dumitrescu RG, Liu Z, Mason JB, Spear SL, Kallakury BV, Freudenheim JL, Shields PG, Carcinogenesis, 1/9/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Other

  • Detection of oxidative damage by 32P-postlabeling: 8-hydroxydeoxyguanosine as a marker of exposure. 
    Povey, A. C., Wilson, V. L., Weston, A., Doan, V. T., Wood, M. L., Essigmann, J. M. and Shields, P.G.
    1/1/1993

Press Mentions

  • People Diagnosed with Lung Cancer Who Quit Smoking Early Have Better Lung Cancer Survival Rates
    People Diagnosed with Lung Cancer Who Quit Smoking Early Have Better Lung Cancer Survival RatesMay 5th, 2023
  • Identifying the Inflammatory Cells Behind Chemo Brain
    Identifying the Inflammatory Cells Behind Chemo BrainFebruary 28th, 2023
  • Moderate Fitness Levels Produce Significantly Larger Immune Response in Breast Cancer Survivors
    Moderate Fitness Levels Produce Significantly Larger Immune Response in Breast Cancer SurvivorsApril 26th, 2022
  • Join now to see all

Grant Support

  • Increasing Minority Participation In Cancer Prevention And ControlNational Cancer Institute2008–2010
  • Genotypic And Phenotypic Response Of Breast Epithelial Cells From WomenNational Center For Research Resources2008–2009
  • University Of The District Of Columbia And The Lombardi*National Cancer Institute2003–2008
  • Genotypic&Phenotypic Response Breast Epithelial Cells From Women- MammoplastyNational Center For Research Resources2007
  • Laboratory Assessment Of Tobacco Use Behavior And Exposure To Toxins Among UsersNational Cancer Institute2007
  • Genotypic And Phenotypic Response Of Breast Epithelial Cells From WomenNational Center For Research Resources2006–2007
  • Molecular Epidemiology Of Secondary Lung CancerNational Cancer Institute2003–2007
  • Genotypic And Phenotypic Response Of Breast Epithelial Cells From WomenNational Center For Research Resources2004
  • Genetic Determinants Of Tobacco Smoke Exposure And HARMNational Center For Research Resources2004
  • Udc/Lcc Partnership For Cancer Research TrainingNational Cancer Institute2001–2003
  • Cancer Research TrainingNational Cancer Institute2001–2002
  • Molecular Epidemiology Of Breast CancerNational Center For Research Resources1999–2002
  • Core--Molecular GeneticsNational Cancer Institute1999–2002
  • Biobehavioral Determinants Of Tobacco Exposure And HARMNational Cancer Institute1999–2002
  • Molecular Epidemiology Of Human Lung CancerDivision Of Basic Sciences - Nci1999
  • Molecular Epidemiology Of Human Breast CancerDivision Of Basic Sciences - Nci1999
  • Development Of Methods For Human Molecular Dosimetry And Molecular EpidemiologyDivision Of Basic Sciences - Nci1999

Hospital Affiliations